NUCLEIC ACID BIOMARKER AND USE THEREOF
The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at an mRNA level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gen...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
15.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at an mRNA level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at an mRNA level is assessed as high. The present invention is also directed to methods of identifying a human subject harboring a tumor or other disease comprising assessing HRG gene expression at an mRNA level in the human subject and withholding a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at an mRNA level is assessed as low. |
---|---|
Bibliography: | Application Number: US201615297775 |